C2ORF61-ALK Fusion FISH Probe
The C2ORF61-ALK Fusion FISH Probe is used to confirm a fusion of the C2ORF61 and ALK genes. The fusion of the C2ORF61 and ALK genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C2ORF61-ALK-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C2ORF61-ALK-20-AQAQ | 20 (40 μL) | 200 μL |
|
ALK Gene Summary
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
Gene Name: ALK Receptor Tyrosine Kinase
Chromosome: CHR2: 29415639 -30144477
Locus: 2p23.2-p23.1
Gene Diseases
The C2ORF61 ALK Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|